High prescription drug costs remain a major challenge for many Americans. The Most Favored Nation (MFN) pricing model would require the United States to pay no more for certain prescription drugs than the lowest price paid by peer countries such as Germany, the United Kingdom, or Canada. While intended to lower drug costs, MFN effectively imports foreign government price controls into the U.S. healthcare system.
